Breast cancer survivors have a high risk of cardiac death as a consequence of heart irradiation during left breast tangential radiotherapy (RT). This study compares the cardiac dose delivered by standard 3D conformal tangential RT (CRT) to that delivered by prospective-gating RT (PGRT) or 5-field intensity-modulated RT (IMRT).
Methods
Patients with early left breast cancer, referred for adjuvant RT to our institution, were enrolled in this study. For each patient, 2 simulation computed tomography scans were acquired: the first during free breathing, and the second on prospective gating during deep inspiration breath-hold. The scans were monitored by the Varian RPM™ respiratory gating system. For each patient, 3 treatment plans were performed: a 3D-CRT and an IMRT plan, each based on the free-breathing scan, and a PGRT plan, based on the deep inspiration breath-hold scan. Dose-volume histograms were compared by means of the Friedman test.
Results
The median mean heart dose was 3 Gy (range 0.9-7.3 Gy) in the CRT plans, 1.9 Gy (range 0.5-3.6 Gy) in the PGRT plans, and 4.5 Gy (range 1.1-10.5 Gy) in the IMRT plans (p = 0.001). The mean heart V25 was 1.2% (range 0%-9.7%), 0% (range 0%-2.0%), and 0.2% (range 0%-7.3%) for CRT, PGRT, and IMRT plans, respectively (p<0.001).
Conclusions
Prospective-gating RT to the left breast offered the best protection of heart and lung, as well as a lower irradiation of the contralateral breast, compared to CRT or IMRT.
DarbySMcGalePCorreaC; Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet2011;378 (9804):1707–1716
2.
Early Breast Cancer Trialists’ Collaborative Group (EBCTG). Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials, Early Breast Cancer Trialists’ Collaborative Group. Lancet2000;355 (9217):1757–1770
3.
GagliardiGBjöhleJLaxIRadiation pneumonitis after breast cancer irradiation: analysis of the complication probability using the relative seriality model. Int J Radiat Oncol Biol Phys2000;46 (2):373–381
4.
DarbySCCutterDJBoermaMRadiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys2010;76 (3):656–665
5.
FajardoLFStewartJRPathogenesis of radiation-induced myocardial fibrosis. Lab Invest1973;29 (2):244–257
6.
SardaroAPetruzzelliMFD’ErricoMPGrimaldiLPiliGPortaluriMRadiation-induced cardiac damage in early left breast cancer patients: risk factors, biological mechanisms, radiobiology, and dosimetric constraints. Radiother Oncol2012;103 (2):133–142
7.
RutqvistLEJohanssonHMortality by laterality of the primary tumour among 55,000 breast cancer patients from the Swedish Cancer Registry. Br J Cancer1990;61 (6):866–868
8.
RutqvistLELaxIFornanderTJohanssonHCardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys1992;22 (5):887–896
9.
RoychoudhuriRRobinsonDPutchaVCuzickJDarbySMøllerHIncreased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based study. BMC Cancer2007;7 (1):9
10.
CorreaCRLittHIHwangWTFerrariVASolinLJHarrisEECoronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer. J Clin Oncol2007;25 (21):3031–3037
11.
NixonAJManolaJGelmanRNo long-term increase in cardiac-related mortality after breast-conserving surgery and radiation therapy using modern techniques. J Clin Oncol1998;16 (4):1374–1379
12.
PurdyJADose to normal tissues outside the radiation therapy patient's treated volume: a review of different radiation therapy techniques. Health Phys2008;95 (5):666–676
13.
KorremanSSPedersenANAarupLRNøttrupTJSpechtLNyströmHReduction of cardiac and pulmonary complication probabilities after breathing adapted radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys2006;65 (5):1375–1380
14.
RemouchampsVMViciniFASharpeMBKestinLLMartinezAAWongJWSignificant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation. Int J Radiat Oncol Biol Phys2003;55 (2):392–406
15.
PedersenANKorremanSNyströmHSpechtLBreathing adapted radiotherapy of breast cancer: reduction of cardiac and pulmonary doses using voluntary inspiration breath-hold. Radiother Oncol2004;72 (1):53–60
16.
HurkmansCWChoBCDamenEZijpLMijnheerBJReduction of cardiac and lung complication probabilities after breast irradiation using conformal radiotherapy with or without intensity modulation. Radiother Oncol2002;62 (2):163–171
17.
MorgantiAGCillaSValentiniVPhase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. Radiother Oncol2009;90 (1):86–92
18.
ChoBCHurkmansCWDamenEMZijpLJMijnheerBJIntensity modulated versus non-intensity modulated radiotherapy in the treatment of the left breast and upper internal mammary lymph node chain: a comparative planning study. Radiother Oncol2002;62 (2):127–136
19.
KruegerEAFraassBAMcShanDLMarshRPierceLJPotential gains for irradiation of chest wall and regional nodes with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys2003;56 (4):1023–1037
20.
FengMMoranJMKoellingTDevelopment and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys2011;79 (1):10–18
21.
MarksLBYorkeEDJacksonAUse of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys2010;76(3)(Suppl):S10–S19
22.
SiegelRNaishadhamDJemalACancer statistics, 2013. CA Cancer J Clin2013;63 (1):11–30
23.
WhelanTJJulianJWrightJJadadARLevineMLDoes locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol2000;18 (6):1220–1229
24.
HeidenreichPASchnittgerIStraussHWScreening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. J Clin Oncol2007;25 (1):43–49
25.
DarbySCMcGalePTaylorCWPetoRLong-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol2005;6 (8): 557–565
26.
DarbySCEwertzMMcGalePRisk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med2013;368 (11):987–998
27.
GagliardiGConstineLSMoiseenkoVRadiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys2010; 76(3)(Suppl):S77–S85
28.
GallucciGStortoGFiorentinoAThe intriguing issue of genetic predisposition and the importance of identification of pre-clinical markers of endothelial damage in radiotherapy-induced cardiotoxicity. Eur Heart J Cardiovasc Imaging2014;15 (2):233
29.
FiorentinoAMazzolaRRicchettiFIntensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity. Cancer Radiother2015
30.
GiraudPDjadi-PratJMorvanE; les Centres Investigateurs du Stic. [Dosimetric and clinical benefits of respiratory-gated radiotherapy for lung and breast cancers: results of the STIC 2003.] Cancer Radiother2012;16 (4):272–281
31.
HjelstuenMHMjaalandIVikströmJDybvikKIRadiation during deep inspiration allows loco-regional treatment of left breast and axillary-, supraclavicular- and internal mammary lymph nodes without compromising target coverage or dose restrictions to organs at risk. Acta Oncol2012;51 (3):333–344
32.
VikströmJHjelstuenMHMjaalandIDybvikKICardiac and pulmonary dose reduction for tangentially irradiated breast cancer, utilizing deep inspiration breath-hold with audio-visual guidance, without compromising target coverage. Acta Oncol2011; 50 (1):42–50
33.
NicoliniGVanettiEClivioAFogliataACozziLPre-clinical evaluation of respiratory-gated delivery of volumetric modulated arc therapy with RapidArc. Phys Med Biol2010;55 (12):N347–N357
34.
ZurlBStranzlHWinklerPKappKSQuantitative assessment of irradiated lung volume and lung mass in breast cancer patients treated with tangential fields in combination with deep inspiration breath hold (DIBH). Strahlenther Onkol2010;186 (3):157–162
35.
KorremanSSPedersenANNøttrupTJSpechtLNyströmHBreathing adapted radiotherapy for breast cancer: comparison of free breathing gating with the breath-hold technique. Radiother Oncol2005;76 (3):311–318
36.
PignolJPOlivottoIRakovitchEA multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol2008;26 (13):2085–2092
37.
LomaxAJCellaLWeberDKurtzJMMiralbellRPotential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes. Int J Radiat Oncol Biol Phys2003;55 (3):785–792
38.
BeckhamWAPopescuCCPatenaudeVVWaiESOlivottoIAIs multibeam IMRT better than standard treatment for patients with left-sided breast cancer?Int J Radiat Oncol Biol Phys2007;69 (3):918–924
39.
JinGHChenLXDengXWLiuXWHuangYHuangXBA comparative dosimetric study for treating left-sided breast cancer for small breast size using five different radiotherapy techniques: conventional tangential field, filed-in-filed, tangential-IMRT, multi-beam IMRT and VMAT. Radiat Oncol2013;8 (1):89
40.
Al-RahbiZSMandhariAl ZRavichandranRDosimetric comparison of intensity modulated radiotherapy isocentric field plans and field in field (FIF) forward plans in the treatment of breast cancer. J Med Phys2013;38 (1):22–29
41.
HallEJIntensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys2006; 65 (1):1–7
42.
GiraudPDjadi-PratJMorelleM; STIC Study Centers. Contribution of respiratory gating techniques for optimization of breast cancer radiotherapy. Cancer Invest2012;30 (4):323–330
43.
LorenzenELTaylorCWMaraldoMInter-observer variation in delineation of the heart and left anterior descending coronary artery in radiotherapy for breast cancer: a multi-centre study from Denmark and the UK. Radiother Oncol2013; 108 (2):254–258
